PHARMA

Hikal Ltd shares jump 1.88% as it ventures into Personal Care with new Panoli facility

By Bharath K S •
Hikal Ltd has begun commercial production at its new cGMP facility in Panoli, marking its entry into the personal care products sector as of September 22, 2026.

Why did Hikal Ltd shares jump today?

Hikal Ltd shares experienced a notable jump of 1.88% on Tuesday, with the stock price climbing to ₹233.45 as of 01:57 PM. This positive movement in the stock market comes directly on the back of a significant company announcement made earlier in the day.

The reason for the investor optimism is Hikal's formal entry into the personal care sector. The company announced the commencement of commercial production at its new, state-of-the-art facility in Panoli. This facility is certified with current Good Manufacturing Practices (cGMP), which is a critical quality standard for manufacturing products that come into contact with skin or the body.

This new multipurpose plant is a strategic move, allowing Hikal to start manufacturing personal care products on a commercial scale. The company highlighted its focus on advanced ingredients, specifically mentioning second-generation UV filters used in sunscreens. Furthermore, Hikal noted it is building a growing pipeline of partnerships with both global and domestic brands, signalling its ambition to become a key player in this new market segment. Investors are reacting positively to this clear expansion into a new, high-potential business vertical beyond the company's traditional pharmaceutical and crop protection operations.

What does Hikal Ltd do?

Hikal Ltd has expanded its business operations by venturing into the personal care sector. The company has commenced commercial production in this new business area through a dedicated manufacturing facility.

The company's entry into personal care is supported by a new multipurpose facility located in Panoli. This facility has been established with cGMP standards and has begun commercial-scale production of personal care products.

Hikal Ltd Financials

In Crores
517
14
Mar 2026
400
-7
Jun 2026
Revenue
Net Profit

Hikal Ltd's financial performance declined from the March 2026 quarter to the June 2026 quarter, with revenue falling from ₹517.0 Crores to ₹399.8 Crores. Profit also decreased, shifting from a positive ₹14.4 Crores in March to a loss of ₹7.4 Crores in June, indicating a downward trend in both revenue and profitability.

Hikal Ltd Shareholding Pattern

Holdings
Promoter
68.85%
FIIs
0.98%
DIIs
7.23%
Public
22.92%

Promoter holding stands at 68.85% of the total share capital. Foreign Institutional Investors (FIIs) hold 0.98% stake in the company, while Domestic Institutional Investors (DIIs) hold 7.23%. Public shareholders hold the remaining 22.92% stake in Hikal Ltd.

Hikal Ltd FAQs

Q: Why did Hikal shares jump 1.88% today?

Press Release- Hikal ventures into Personal Care: New cGMP Panoli facility begins Commercial Production.. This corporate action caught investor attention, leading to increased trading activity in the stock.

Q: What is the shareholding pattern of Hikal Ltd?

As per the latest data, promoters hold 68.85% stake in Hikal Ltd, while FII holding stands at 0.98%. Domestic institutional investors hold 7.23%, and public shareholders account for 22.92% of the equity.

Q: What is the current stock price of Hikal Ltd?

Hikal Ltd shares are currently trading at ₹233.45, recording a gain of 1.88% from the previous close.

Q: What is the market capitalization of Hikal Ltd?

The company currently has a market capitalization of ₹2878.46 crore, reflecting its valuation in the Indian equity market.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. The stock prices mentioned are as of the time of writing. Bharath K S and the publisher do not hold any positions in the stocks mentioned. Please consult a SEBI-registered financial advisor before making any investment decisions.